Analysis of leucocyte antibodies, cytokines, lysophospholipids and cell microparticles in blood components implicated in post-transfusion reactions with dyspnoea

被引:25
作者
Maslanka, K. [1 ]
Uhrynowska, M. [1 ]
Lopacz, P. [1 ]
Wrobel, A. [1 ]
Smolenska-Sym, G. [1 ]
Guz, K. [1 ]
Lachert, E. [1 ]
Ostas, A. [1 ]
Brojer, E. [1 ]
机构
[1] Inst Hematol & Transfus Med, Dept Immunohematol & Immunol Transfus Med, PL-00791 Warsaw, Poland
关键词
cytokines; leucocyte antibodies; lysophospholipids; microparticles; pulmonary post-transfusion reactions; ACUTE LUNG INJURY; POLYMERASE-CHAIN-REACTION; BIOACTIVE LIPIDS; ROUTINE STORAGE; TRANSFUSION; PLASMA; ALLOANTIBODIES; NEUTROPHILS; FREQUENCIES; PREVENTION;
D O I
10.1111/vox.12190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and ObjectivesPost-transfusion reactions with dyspnoea (PTR) are major causes of morbidity and death after blood transfusion. Transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO) are most dangerous, while transfusion-associated dyspnoea (TAD) is a milder respiratory distress. We investigated blood components for immune and non-immune factors implicated in PTR. Material and MethodsWe analysed 464 blood components (RBCs, PLTs, L-PLTs, FFP) transfused to 271 patients with PTR. Blood components were evaluated for 1/antileucocyte antibodies, 2/cytokines: IL-1, IL-6, IL-8, TNF-, sCD40L, 3/lysophosphatidylcholines (LysoPCs), 4/microparticles (MPs) shed from plateletes (PMPs), erythrocytes (EMPs) and leucocytes (LMPs). ResultsAnti-HLA class I/II antibodies or granulocyte-reactive anti-HLA antibodies were detected in 182% of blood components (RBC and FFP) transfused to TRALI and in 05% of FFP transfused to TAD cases. Cytokines and LysoPCs concentrations in blood components transfused to PTR patients did not exceed those in blood components transfused to patients with no PTR. Only EMPs percentage in RBCs transfused to patients with TRALI was significantly higher (P<005) than in RBCs transfused to patients with no PTR. ConclusionImmune character of PTR was confirmed mainly in 1/5 TRALI cases. Among non-immune factors, only MPs released from stored RBCs are suggested as potential mediators of TRALI. Our results require further observations in a more numerous and better defined group of patients.
引用
收藏
页码:27 / 36
页数:10
相关论文
共 62 条
[1]  
[Anonymous], 2011, AN KRWI ODDZ JEJ SKL
[2]  
[Anonymous], 2011, ANN REP
[3]  
[Anonymous], 2011, Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2011
[4]  
Babaev A., 2014, J Anesth Crit Care-Open Access, V1, P2
[5]  
BARNARD RD, 1951, NEW YORK STATE J MED, V51, P2399
[6]   Microparticles from Stored Red Blood Cells Activate Neutrophils and Cause Lung Injury after Hemorrhage and Resuscitation [J].
Belizaire, Ritha M. ;
Prakash, Priya S. ;
Richter, Jillian R. ;
Robinson, Bryce R. ;
Edwards, Michael J. ;
Caldwell, Charles C. ;
Lentsch, Alex B. ;
Pritts, Timothy A. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2012, 214 (04) :648-655
[7]   Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury [J].
Bierling, P. ;
Bux, J. ;
Curtis, B. ;
Flesch, B. ;
Fung, I. ;
Lucas, G. ;
Macek, M. ;
Muniz-Diaz, E. ;
Porcelijn, I. ;
Reil, A. ;
Sachs, U. ;
Schuller, R. ;
Tsuno, N. ;
Uhrynowska, M. ;
Urbaniak, S. ;
Valentin, N. ;
Wikman, A. ;
Zupanska, B. .
VOX SANGUINIS, 2009, 96 (03) :266-269
[8]   Antibody-mediated (immune) transfusion-related acute lung injury [J].
Bux, J. .
VOX SANGUINIS, 2011, 100 (01) :122-128
[9]   NA GENE-FREQUENCIES IN THE GERMAN POPULATION, DETERMINED BY POLYMERASE CHAIN-REACTION WITH SEQUENCE-SPECIFIC PRIMERS [J].
BUX, J ;
STEIN, EL ;
SANTOSO, S ;
MUELLERECKHARDT, C .
TRANSFUSION, 1995, 35 (01) :54-57
[10]   Characterization of a new alloantigen (SH) on the human neutrophil Fc gamma receptor IIIb [J].
Bux, J ;
Stein, EL ;
Bierling, P ;
Fromont, P ;
Clay, M ;
Stroncek, D ;
Santoso, S .
BLOOD, 1997, 89 (03) :1027-1034